Argus Downgrades Novo Nordisk A/S (NVO) to Hold From Buy

2 hours ago 1

Noor Ul Ain Rehman

Wed, December 10, 2025 astatine 10:28 AM CST 2 min read

Novo Nordisk A/S (NYSE:NVO) is 1 of the best pharma stocks to put in. Argus expert Jasper Hellweg downgraded Novo Nordisk A/S (NYSE:NVO) to Hold from Buy connected December 8, without assigning a terms target. The expert told investors successful a probe enactment that the institution is experiencing a driblet successful marketshare successful its GLP-1 cause category, including Ozempic and Wegovy.

Berenberg Lowers Novo Nordisk (NVO) Price Target to DKK 400, Maintains Buy Rating

It is besides agreeing to bring the prices of these drugs down successful the United States markets, and is expected to soon spot the emergence of generic versions of these products successful immoderate planetary markets. At the aforesaid time, immoderate cardinal objective trials by Novo Nordisk A/S (NYSE:NVO) person “failed to impress”, according to the analyst, adding that the caller semaglutide trials bash not corroborate superiority compared to placebo successful the simplification of progression successful Alzheimer’s disease.

Separately, Novo Nordisk A/S (NYSE:NVO) submitted an sNDA to the FDA for a higher dose of semaglutide injection 7.2 mg for usage successful conjunction with higher carnal enactment and a reduced-calorie fare for chronic value absorption successful adults with obesity. Management stated that the reappraisal is anticipated wrong 1-2 months nether the CNPV expedited programme aft the FDA accepts the filing. If approved, the investigational semaglutide 7.2 mg injection would supply the enactment of a higher dose for accrued value nonaccomplishment imaginable successful adults with obesity.

Novo Nordisk A/S (NYSE:NVO) is simply a planetary healthcare institution specializing successful diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products. Its operations are divided into 2 concern segments: biopharmaceuticals and diabetes and obesity care. The second conception covers GLP-1, insulin, and different protein-related products.

While we admit the imaginable of NVO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.